Insider Trading April 10, 2026 03:32 PM

Photronics Director Sells $216K in Stock as Company Posts Q1 Beat and Advances Mask Technology

Director Lee Kang Jyh sells 5,000 shares and exercises options; company reports fiscal Q1 2026 beat and readies AMOLED photomask capacity in Korea

By Caleb Monroe PLAB
Photronics Director Sells $216K in Stock as Company Posts Q1 Beat and Advances Mask Technology
PLAB

Photronics Inc. director Lee Kang Jyh sold 5,000 shares of common stock on April 8, 2026, for $216,350 and exercised options on 5,000 shares the same day. The stock is trading near a 52-week high after a sizable one-year gain. Separately, Photronics reported fiscal Q1 2026 results that outpaced expectations and confirmed plans to install a new mask writer at its Korea facility for AMOLED photomask production.

Key Points

  • Director Lee Kang Jyh sold 5,000 shares on April 8, 2026 at $43.27 per share, totaling $216,350, and exercised options for 5,000 shares at $8.60 the same day for a $43,000 exercise cost.
  • Photronics reported fiscal Q1 2026 EPS of $0.61, beating the $0.5267 estimate by 15.82%, and revenue of $225.07 million versus an expected $220.83 million, a 1.92% upside.
  • Company is installing a new mask writer at its Korea facility slated for fiscal Q2 2026 to produce AMOLED photomasks; Craig-Hallum raised its price target to $48 from $42 and maintained a Buy rating.

Photronics Inc (NASDAQ:PLAB) disclosed a director-level stock transaction on April 8, 2026, when director Lee Kang Jyh sold 5,000 shares of common stock at $43.27 per share, producing a gross transaction value of $216,350.

On the same date, Lee exercised stock options to acquire 5,000 shares at an exercise price of $8.60 per share, for a total exercise cost of $43,000. After completing both the sale and the option exercise, Lee Kang Jyh is recorded as directly owning 385,850 shares of Photronics common stock.

The director’s sale took place while Photronics shares were trading close to a 52-week high of $45.40, a level reached following a 151% return for the stock over the past 12 months.


Independent analysis cited by the company indicates a valuation concern at current market prices. According to InvestingPro analysis, the stock appears overvalued at current levels based on Fair Value calculations. The same service notes there are comprehensive Pro Research Reports and 14+ additional ProTips available for investors seeking deeper data on PLAB.

Photronics also released its fiscal first-quarter 2026 financial results, which showed earnings per share of $0.61. That figure exceeded the analyst consensus of $0.5267, representing a beat of 15.82% versus expectations. Revenue for the quarter came in at $225.07 million, ahead of the forecasted $220.83 million, a difference that corresponds to a 1.92% increase over the projection.

Following the quarterly disclosure, Craig-Hallum adjusted its price target for Photronics upward to $48 from $42 while maintaining a Buy rating. The firm attributed this outlook in part to Photronics’ positioning as semiconductor manufacturers increasingly outsource photomask production.

On the technology front, Photronics announced plans to install a new, advanced mask writer at its Korea facility, with the equipment slated to come online in fiscal Q2 2026. The company described the unit as the first of its kind that will be capable of producing AMOLED photomasks and said it will improve resolution and accuracy.

Corporate governance items were also resolved at the company’s recent annual meeting. Shareholders elected eight directors to the board and approved executive compensation and auditor appointments.


These developments - an insider sale paired with option exercise, a quarterly earnings beat, a higher price target from an analyst, and a capital deployment into mask-writing capability - together outline the current corporate and market backdrop for Photronics as it moves toward enhancing its photomask production and serving outsourcing demand from semiconductor customers.

Risks

  • Valuation concern - InvestingPro analysis indicates the stock appears overvalued at current levels based on Fair Value calculations, posing potential market risk to investors.
  • Share price is trading near its 52-week high of $45.40 after a 151% 12-month run, which can increase sensitivity to market pullbacks or profit-taking.
  • Operational timing - the new mask writer is slated for fiscal Q2 2026, and any delays or implementation issues could affect planned capacity expansion for AMOLED photomask production.

More from Insider Trading

Airbnb CFO Sells $491,212 in Stock as Company Completes Debt Refinance and Draws Varied Analyst Targets Apr 10, 2026 Ginkgo Bioworks director Shetty disposes of $175k in shares to cover tax on vested PSUs Apr 10, 2026 Cirrus Logic General Counsel Sells Nearly $1.6M of Stock as Company Posts Strong Q3 Results Apr 10, 2026 Dianthus CFO Sells $738,844 in DNTH Stock; Exercises Options Under Prearranged 10b5-1 Plan Apr 10, 2026 Kymera CBO Sells $500K in Stock Following Option Exercise as Analysts Weigh In Apr 10, 2026